User profiles for "author:Andreas Behren"
Andreas BehrenOlivia Newton-John Cancer Research Institute Verified email at onjcri.org.au Cited by 7262 |
[HTML][HTML] γδ T cells in the tumor microenvironment—Interactions with other immune cells
KF Chan, JDG Duarte, S Ostrouska… - Frontiers in …, 2022 - frontiersin.org
A growing number of studies have shown that γδ T cells play a pivotal role in mediating the
clearance of tumors and pathogen-infected cells with their potent cytotoxic, cytolytic, and …
clearance of tumors and pathogen-infected cells with their potent cytotoxic, cytolytic, and …
Whole-genome landscapes of major melanoma subtypes
Melanoma of the skin is a common cancer only in Europeans, whereas it arises in internal
body surfaces (mucosal sites) and on the hands and feet (acral sites) in people throughout …
body surfaces (mucosal sites) and on the hands and feet (acral sites) in people throughout …
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
ML Burr, CE Sparbier, YC Chan, JC Williamson… - Nature, 2017 - nature.com
Cancer cells exploit the expression of the programmed death-1 (PD-1) ligand 1 (PD-L1) to
subvert T-cell-mediated immunosurveillance,. The success of therapies that disrupt PD-L1 …
subvert T-cell-mediated immunosurveillance,. The success of therapies that disrupt PD-L1 …
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
M Rigau, S Ostrouska, TS Fulford, DN Johnson… - Science, 2020 - science.org
INTRODUCTION T cells represent a key component of the immune system that can
recognize foreign molecules (antigens) via cognate cell surface receptors termed T cell …
recognize foreign molecules (antigens) via cognate cell surface receptors termed T cell …
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Group 2 innate lymphoid cells (ILC2s) are essential to maintain tissue homeostasis. In
cancer, ILC2s can harbor both pro-tumorigenic and anti-tumorigenic functions, but we know …
cancer, ILC2s can harbor both pro-tumorigenic and anti-tumorigenic functions, but we know …
Evaluation of combination nivolumab and ipilimumab immunotherapy in patients with advanced biliary tract cancers: subgroup analysis of a phase 2 nonrandomized …
Importance Biliary tract cancers represent a rare group of malignant conditions with very
limited treatment options. Patients with advanced disease have a poor outcome with current …
limited treatment options. Patients with advanced disease have a poor outcome with current …
A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients
J Cursons, F Souza-Fonseca-Guimaraes… - Cancer immunology …, 2019 - AACR
Natural killer (NK) cell activity is essential for initiating antitumor responses and may be
linked to immunotherapy success. NK cells and other innate immune components could be …
linked to immunotherapy success. NK cells and other innate immune components could be …
Immunotherapy of ipilimumab and nivolumab in patients with advanced neuroendocrine tumors: a subgroup analysis of the CA209-538 clinical trial for rare cancers
O Klein, D Kee, B Markman, M Michael… - Clinical Cancer …, 2020 - AACR
Purpose: Combination immunotherapy with anti–CTLA-4 and anti–PD-1 blockade has
demonstrated significant clinical activity across several tumor types. Neuroendocrine tumors …
demonstrated significant clinical activity across several tumor types. Neuroendocrine tumors …
[HTML][HTML] BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
EF Lee, TJ Harris, S Tran, M Evangelista… - Cell death & …, 2019 - nature.com
Malignant melanoma is one of the most difficult cancers to treat due to its resistance to
chemotherapy. Despite recent successes with BRAF inhibitors and immune checkpoint …
chemotherapy. Despite recent successes with BRAF inhibitors and immune checkpoint …
[HTML][HTML] Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
S Chang-Hao Tsao, J Weiss, C Hudson, C Christophi… - Scientific reports, 2015 - nature.com
We assessed the utility of droplet digital PCR (ddPCR) to evaluate the potential of using
circulating tumour DNA (ctDNA) as a post therapy monitoring tool in melanoma by …
circulating tumour DNA (ctDNA) as a post therapy monitoring tool in melanoma by …